NAD Takes Initiative In Reviews Of Anti-Aging, Cellulite Claims In 2004
This article was originally published in The Rose Sheet
Executive Summary
Skin care marketers are likely to step up challenges to competitors' ad claims regarding wrinkle reduction as the market for anti-aging products grows, according to David Mallen, Assistant Director and Senior Attorney at the National Advertising Division of the Council of Better Business Bureaus
You may also be interested in...
Is StriVectin Better Than Botox? Not Without NDA Approval, FDA Says
Klein-Becker's signature statement for StriVectin-SD anti-aging cream - "Better than Botox?" - constitutes a structure/function claim that would require the product to be regulated as a drug, the agency states in a 1warning letter recently posted on its Web site
Is StriVectin Better Than Botox? Not Without NDA Approval, FDA Says
Klein-Becker's signature statement for StriVectin-SD anti-aging cream - "Better than Botox?" - constitutes a structure/function claim that would require the product to be regulated as a drug, the agency states in a 1warning letter recently posted on its Web site
NAD Keeps An Eye On Anti-Aging Claims With Olay Regenerist Inquiry
The National Advertising Division of the Council of Better Business Bureaus recommended Procter & Gamble modify ads for Olay Regenerist Eye Lifting Serum that imply the product can produce results similar to eyelift surgery following a recent inquiry